• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There aren't enough data on how exposure to ADHD for a long time could affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the advantages of taking them against potential risks to the fetus. The doctors don't have the information to give clear advice however they can provide information about risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at greater risk of fetal malformations, or structural birth defects. The researchers used a large, population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who took stimulants during the early stages of pregnancy and those who had not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to ensure that the classification was accurate and to minimize any bias.

However, the researchers' study was not without its flaws. The researchers were unable to, in the first place, to separate the effects triggered by the medication from the disorder. This makes it difficult for researchers to establish whether the small associations observed among the exposed groups were due to the use of medications or caused by comorbidities. Researchers also did not examine long-term outcomes for the offspring.

The study did find that infants whose mothers had taken ADHD medication during pregnancy were at a higher risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had taken off their medication prior to or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not affected by the stimulant medications used during pregnancy.

Women who took stimulant Most popular Adhd Medication medications during pregnancy also had a higher likelihood of having to have caesarean sections or one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during early pregnancy may be offset by the greater benefit for both mother and child of continued treatment for the woman's condition. Physicians should discuss this with their patients and, if possible, assist them in developing strategies to improve their coping abilities which can reduce the impact of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and treated with medication, the question of whether to keep or end treatment during pregnancy is one that more and more doctors confront. These decisions are often taken without clear and authoritative evidence. Instead, doctors have to take into account their own experience, the experience of other doctors, and the research on the subject.

Particularly, the issue of possible risks to the infant can be difficult. Many of the studies on this issue are based on observational evidence rather than controlled research and their conclusions are often contradictory. The majority of studies restrict their analysis to live births, which can underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study discussed in the journal club addresses these shortcomings, by examining both information on deceased and live births.

The conclusion: While certain studies have demonstrated that there is a positive correlation between ADHD medications and the possibility of certain birth defects, other studies have found no such relationship and the majority of studies have a neutral or slightly negative impact. In every case, a careful analysis of the potential risks and benefits is required.

It can be difficult, if not impossible for women with ADHD to stop taking their medication. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of isolation. Furthermore, a loss of medication can interfere with the ability to complete work-related tasks and safely drive, which are important aspects of a normal life for many people with ADHD.

She suggests that women who are unsure whether to continue taking the medication or stop it due to their pregnancy should educate family members, coworkers, and acquaintances about the condition, the effects on daily functioning, and the benefits of keeping the current treatment plan. It can also help women feel supported in her decision. Certain medications can pass through the placenta. If the patient decides not to take her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug may be transferred to her baby.

Risk of Birth Defects

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns about what impact the drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this subject. With two massive data sets, researchers were able to analyze more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. Researchers found that while the overall risk is low, first-trimester ADHD exposure to medication was associated with slightly higher rates of specific heart defects such as ventriculoseptal defect.

The researchers behind the study found no connection between early medication use and other congenital anomalies, such as facial clefting or club foot. The results are in the same vein as previous studies that showed an insignificant, but small increase in the number of cardiac malformations among women who started taking ADHD medication prior to the birth of their child. The risk increased in the latter half of pregnancy, when a lot of women stopped taking their medication.

Women who were taking ADHD medication in the first trimester were more likely to require a caesarean delivery, have a low Apgar after birth and have a baby that needed help breathing after birth. However the researchers of the study were not able to eliminate selection bias by limiting the study to women who did not have other medical issues that could have contributed to the findings.

The researchers hope their study will help inform the clinical decisions of doctors who treat pregnant women. They suggest that although the discussion of the risks and benefits is crucial but the decision to stop or keep medication must be based on each woman's needs and the severity of her ADHD symptoms.

The authors also caution that while discontinuing the medications is an alternative, it is not an option that is recommended due to the high incidence of depression and other mental health problems in women who are pregnant or post-partum. Research has also shown that women who stop taking their medication will have a harder transitioning to life without them after the baby is born.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women suffering from ADHD are often faced with a number of difficulties when they have to manage their symptoms, attend doctor appointments, prepare for the birth of a baby and adjust to a new routine. Therefore, many women decide to continue taking their adhd medications for adults with anxiety medication throughout the pregnancy.

The risk to a breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk in low amounts. However, the frequency of exposure to medications by the newborn can vary depending on the dosage, frequency it is taken and the time of day it is administered. Additionally, individual medications enter the baby's system differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn isn't fully known.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the lack of research. It's a difficult choice for the woman who must weigh the advantages of taking her medication as well as the risks to the embryo. In the meantime, until more information is available, GPs can inquire about pregnant patients if they have an history of ADHD or if they intend to take medication in the perinatal phase.

Many studies have shown that women can continue to take their adhd medication names list medication in a safe manner while breastfeeding and during pregnancy. In response, a rising number of patients are opting to do so. They have concluded after consulting with their doctors, that the benefits of continuing their current medication outweigh any risk.

Women who suffer from ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help pregnant people with ADHD recognize their symptoms and underlying disorder, learn about available treatment options and strengthen existing coping with adhd without medication strategies. This should involve an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. The pregnancy counselling should consist of the discussion of a plan for management for both mother and child, monitoring for signs of deterioration and the need for adjustments to the medication regimen.